Evidence map›Paper›PMID 23236151›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes.

Shaun D McCullough, Xiaojiang Xu, Sharon Y R Dent, Stefan Bekiranov, Robert G Roeder, Patrick A Grant

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. UPS writes a new saga of SAGA.Biochimica et biophysica acta. Gene regulatory mechanisms · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. TheJournal of clinical medicine · 2019
    Review
  14. Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2019
    Review
  15. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2019
    Review
  16. Review
  17. Article
  18. Spinal RNF20-Mediated Histone H2B Monoubiquitylation Regulates mGluR5 Transcription for Neuropathic Allodynia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shaun D McCulloughDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Xiaojiang Xu
Sharon Y R Dent
Stefan Bekiranov
Robert G Roeder
Patrick A Grant
University of Virginia · USCancer Research Center · USRockefeller University · US

Funding

Translational Control in the Hepatitis C VirusS06GM008136 · NIGMS · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI KUEHN, GLENN D · 1989 to 2011
$23.2M
TRAINING IN CELL AND MOLECULAR BIOLOGYT32GM008136 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI STUKENBERG, P. TODD · 1985 to 2020
$8.5M
Mechanisms of p53 target gene activation in DNA damage responsesR01CA129325 · NCI · ROCKEFELLER UNIVERSITY · PI ROEDER, ROBERT G · 2007 to 2011
$4.0M
Spinocerebellar ataxia 7 protein function.R01NS049065 · NINDS · UNIVERSITY OF VIRGINIA · PI GRANT, PATRICK A · 2006 to 2010
$1.7M
Defining USP22 Functions During Mammalian DevelopmentR01GM096472 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DENT, SHARON Y. R. · 2012 to 2015
$1.3M
NCI NIH HHS R01 CA129325NIGMS NIH HHS R01 GM096472NIGMS NIH HHS S06 GM008136NIGMS NIH HHS T32 GM008136NIGMS NIH HHS T32-GM08136NINDS NIH HHS R01 NS049065NINDS NIH HHS R01NS049065
6 · The paper itself

Abstract

Spinocerebellar ataxia type 7 (SCA7) is an autosomal-dominant neurodegenerative disorder that results from polyglutamine expansion of the ataxin-7 (ATXN7) protein. Remarkably, although mutant ATXN7 is expressed throughout the body, pathology is restricted primarily to the cerebellum and retina. One major goal has been to identify factors that contribute to the tissue specificity of SCA7. Here we describe the development and use of a human astrocyte cell culture model to identify reelin, a factor intimately involved in the development and maintenance of Purkinje cells and the cerebellum as a whole, as an ATXN7 target gene. We found that polyglutamine expansion decreased ATXN7 occupancy, which correlated with increased levels of histone H2B monoubiquitination, at the reelin promoter. Treatment with trichostatin A, but not other histone deacetylase inhibitors, partially restored reelin transcription and promoted the accumulation of mutant ATXN7 into nuclear inclusions. Our findings suggest that reelin could be a previously unknown factor involved in the tissue specificity of SCA7 and that trichostatin A may ameliorate deleterious effects of the mutant ATXN7 protein by promoting its sequestration away from promoters into nuclear inclusions.

Indexed as

AstrocytesAtaxin-7Cell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsHEK293 CellsHistone Deacetylase InhibitorsHistonesHumansHydroxamic AcidsIntranuclear Inclusion BodiesLentivirusModels, BiologicalNerve Tissue ProteinsPeptidesPromoter Regions, GeneticProtein BindingAtaxin-7ATXN7 protein, humanCell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsHistone Deacetylase InhibitorsHistonesHydroxamic AcidsNerve Tissue ProteinsPeptidespolyglutamineReelin ProteinRELN protein, humanRNA, MessengerSerine Endopeptidasestrichostatin A

Identifiers

PMID23236151
PMCPMC3535616
OpenAlexW1987849987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.